Nortem Biogroup (XPAR:MLBIO) Net Income : €0.50 Mil (TTM As of Dec. 2022)

View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Nortem Biogroup's Net Income for the six months ended in Dec. 2022 was €0.50 Mil. Its Net Income for the trailing twelve months (TTM) ended in Dec. 2022 was €0.50 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Nortem Biogroup's Earnings per Share (Diluted) for the six months ended in Dec. 2022 was €0.19.

Nortem Biogroup Net Income Historical Data

The historical data trend for Nortem Biogroup's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Net Income Chart

Nortem Biogroup Annual Data

Trend

Dec21

Dec22

Net Income

0.56

0.50

Nortem Biogroup Semi-Annual Data
	Dec21	Dec22
Net Income	0.56	0.50

Nortem Biogroup Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Nortem Biogroup's Net Income for the fiscal year that ended in Dec. 2022 is calculated as

	Net Income		(A: Dec. 2022 )
=	Pre-Tax Income	+	Tax Provision	+	Net Income (Discontinued Operations)	+	Others
=	0.57	+	-0.07	+	0	+	5.5511151231258E-17
=	0.50

Nortem Biogroup's Net Income for the quarter that ended in Dec. 2022 is calculated as

	Net Income		(Q: Dec. 2022 )
=	Pre-Tax Income	+	Tax Provision	+	Net Income (Discontinued Operations)	+	Others
=	0.57	+	-0.07	+	0	+	5.5511151231258E-17
=	0.50

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income for the trailing twelve months (TTM) ended in Dec. 2022 was €0.50 Mil.

Nortem Biogroup (XPAR:MLBIO) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Nortem Biogroup's Earnings per Share (Diluted) (EPS) for the quarter that ended in Dec. 2022 is calculated as

Earnings per Share (Diluted) (Q: Dec. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(0.5	-	0)	/	2.579
	=	0.19

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.

Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.

Nortem Biogroup Net Income Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Net Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500

Website

https://www.nortembiogroup.com

Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines